Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer. - Wikidata - wikimedia - TriplyDB

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

http://www.wikidata.org/entity/Q33653799

about

The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.Preoperative evaluation of risk of ovarian malignancy algorithm index in prediction of malignancy of adnexal masses HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.Protein biomarkers of ovarian cancer: the forest and the trees Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample.Ovarian Cancer Tests and Treatment.Serum HE4 is more suitable as a biomarker than CA125 in Chinese women with benign gynecologic disorders Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability Designing early detection programs for ovarian cancer.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.HE4, CA-125, and cystic ovarian mass Diagnosis and management of peritoneal metastases from ovarian cancer.Identifying post-menopausal women at elevated risk for epithelial ovarian cancer High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer.Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.Biomarker testing for ovarian cancer: clinical utility of multiplex assays The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors.Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis.Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses.Value of symptom-triggered diagnostic evaluation for ovarian cancer.Ovarian cancer: biomarker proteomic diagnosis in progress.The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.microRNA and Ovarian Cancer.Detection of Human Epididymis Protein 4 (HE4) in Human Serum Samples Using a Specific Monoclonal Antibody-Based Sandwich Enzyme-Linked Immunosorbent Assay (ELISA).Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.A GPS-Based Methodology to Analyze Environment-Health Associations at the Trip Level: Case-Crossover Analyses of Built Environments and Walking.Comparison of the Serum Level of Cancer Antigen 125 and Human Epididymis Protein 4 in Ovarian Cancer Patients and Healthy Groups in Isfahan City.HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer.Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

P2860

Q26992102-F03E1B0E-789C-4AC0-BBB4-CF27CA1EF680 Q27009306-4ACFA16D-F435-4F14-B1AD-1F638F3DA727 Q33733786-12CCCE27-DB65-4D44-A110-39CBB04E55CC Q33918256-23DAA6F3-DD00-4598-8A5B-1952EF0F4031 Q34621826-2383336B-42B5-4233-A183-54E73DD0DE84 Q34634143-0AB5C9A0-329A-4CE6-BE32-61F219059799 Q35017292-D830B622-50D8-40C7-A7B1-449867AD0D0F Q35021181-C6F5C46A-399D-4024-87CF-B4A63F5FE5C2 Q35115543-3597554D-F98C-463A-B410-3524BE635693 Q35160147-40E12511-1DC9-458E-8794-3C70AF9C3459 Q35207172-FE656C90-065B-4D81-BC20-218109915EAF Q35612779-EF419539-6FA2-4920-BF54-147E2F722E41 Q35663640-844A6C5B-417C-4CBF-AB8B-B815E43BCD6E Q35690554-35013FA5-C072-43FB-A090-92AB9E3BB7FE Q35760155-622ACA6F-4C45-4736-8795-1BB65921F095 Q35837949-B66DE4E4-C01B-413E-B02E-50D1DF7C7C53 Q35886081-C3986AE6-6CC1-4BC0-AE3E-D6663B63D72B Q36128985-DAEC7681-F27F-49A7-9B66-D0E270A7E17E Q36331643-17B5E8EE-C8DC-45D6-B2C5-AC2112A18F54 Q36346403-67ACB1ED-C89C-4C58-A897-C58E9F2D8B66 Q36385490-9A7D94CA-2576-40C0-BB4F-51EE04642BAB Q36400522-2AF6628E-9B88-4199-9BB0-06AA7C12A041 Q36446886-362E3F95-423A-400F-AEB4-CC2E860CD2C2 Q36634141-11F476FE-09E6-4172-A1EB-E9419D161DA6 Q36897149-BE529308-EEDA-4AC6-BCF3-9188F399F5E5 Q36996525-6C2FD397-DF9D-4903-BF2E-81ACA79A633D Q37053905-809A4497-6710-4590-AF9C-32972F037102 Q37093435-1C54C8AD-C4F8-479E-8941-9D3729657112 Q37188163-AC2B7D07-A66E-4412-85BD-A7F2CB2EF19D Q37359954-C8058A27-9B61-4B3E-BE88-B9EAC8D1A076 Q37524514-455C30B4-2102-47CE-84AF-62641FFBFE93 Q38040333-04059B73-F383-458A-B671-E025FE1C0062 Q38653169-67614E7B-8F9A-4014-92F6-AA3212B24D4B Q38667018-C268803F-C6FD-448E-A7AE-15D9763BB662 Q38811840-84192050-F612-4BDA-AD61-E68FC1052F44 Q39326953-210D107B-2B96-4DBF-A443-9E5D093C26E8 Q39360191-E04972D9-228D-4FEA-9175-01B684723AE7 Q47124965-F21D91CE-A8A0-45E4-998D-CB9B4A94B893 Q51091632-6AE6EAAF-158C-4112-A5B6-AC00C5CF4B00 Q52941950-BA844141-19D5-4ACA-B132-484A4813C1B4

P2860

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

http://www.wikidata.org/entity/Q33653799

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

@ast

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

@en

type

label

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

@ast

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

@en

prefLabel

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

@ast

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

@en

P1433

Q33653799-DA99CBF9-D2B1-4F84-92F0-4D345BB613E2

P1476

Q33653799-A9BFDAA3-F502-403A-81B9-5E98AC47986C

P2093

Q33653799-4E9B7B7A-1241-4DE9-A50F-976799F6536D

Q33653799-6D58B5BC-213D-495B-94CF-D7383752B4B0

Q33653799-98764223-3440-4300-AEEC-25D6E470A629

Q33653799-B72EB998-DC55-479F-BCBA-BA32C88AFCC2

Q33653799-BE1C0383-47B2-4A0F-BEFB-44BD99DB6DFD

Q33653799-E815B9EF-7797-45A4-A828-4783453511F5

Q33653799-EF6A7711-FCF5-40E0-BF2F-94E53272419B

P2860

Q33653799-09511927-4C6E-43FC-A60C-0FD2A98E2F75

Q33653799-0D55B262-EB61-4D57-8F89-FA3E17504C96

Q33653799-157DD14A-3AA2-417E-8192-33CEC3CD6255

Q33653799-2BB9F471-D6DD-4592-9695-47FA40F7A8D5

Q33653799-42E87A21-D4AC-4FA6-AF9C-D83221B280D5

Q33653799-438EE6A2-D6A9-466E-8601-3ACF23CC528D

Q33653799-4A64B60D-87FA-457A-B995-DFC8765D91EE

Q33653799-66ADC31B-2A5C-4F57-B35F-6FD74E3D4976

Q33653799-6B1A9EFF-AEE6-4C74-85AA-A0C486F09C13

Q33653799-6E53F398-3264-47E6-BBD1-F8F327DDCAAF

P304

Q33653799-B9CA1AF1-6086-4477-B60A-7C73215407A7

P31

Q33653799-2C23A4ED-34A1-4AB9-893E-F0DD16C4CE13

P356

Q33653799-7BE1880B-D20F-46C6-8B89-86D4FD9F596D

P407

Q33653799-B5FDF4A0-1386-40FD-BCB3-361C707151FA

P433

Q33653799-B23816F6-79D7-4824-B6DC-E0FCC850A67D

P478

Q33653799-3355E626-AE7F-4B81-B1A5-95A351305242

P50

Q33653799-06B940E8-A6DE-446A-8C21-BD87B9DA2E3C

P577

Q33653799-CA5EB6BA-ACF8-4AA0-8B2A-F1108F563781

P5875

Q33653799-0B3873B1-7A7A-4CED-9C04-412147CC79DC

P698

Q33653799-648DDFEC-4ACE-4C5A-9EAC-89F6AF89F5CF

P921

Q33653799-F13C108D-E00E-4173-88CA-676738F2A5E6

P932

Q33653799-913F8FA6-116F-4942-8BA9-D7B242CE017C

P356

J.YGYNO.2009.10.087

P1433

Gynecologic Oncology

P1476

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer

@en

P2093

Charles W Drescher

http://www.w3.org/2001/XMLSchema#string

Kimberly A Lowe

http://www.w3.org/2001/XMLSchema#string

Lindsay Bergan

http://www.w3.org/2001/XMLSchema#string

M Robyn Andersen

http://www.w3.org/2001/XMLSchema#string

Nathalie Scholler

http://www.w3.org/2001/XMLSchema#string

Nicole Urban

http://www.w3.org/2001/XMLSchema#string

Pamela Paley

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2007

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

Frequency of symptoms of ovarian cancer in women presenting to primary care clinics.

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.

Potential markers that complement expression of CA125 in epithelial ovarian cancer.

Ovarian carcinoma diagnosis.

New tumor markers: CA125 and beyond.

Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.

Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.

P304

378-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2009.10.087

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40038878

http://www.w3.org/2001/XMLSchema#string

P698

19945742

http://www.w3.org/2001/XMLSchema#string

P921

P932

2822097

http://www.w3.org/2001/XMLSchema#string